Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0383820140770010013
Tuberculosis and Respiratory Diseases
2014 Volume.77 No. 1 p.13 ~ p.17
Outcomes of Second-Line Chemotherapy for Advanced Non-Small Cell Lung Cancer in One Institution
Lee Seok-Jeong

Kang Hyun-Ju
Kim Seo-Woo
Ryu You-Ju
Lee Jin-Hwa
Kim Yoo-Kyung
Chang Jung-Hyun
Abstract
Background: This study analyzed the negative prognostic factors in patients who received second-line chemotherapy for advanced inoperable non-small cell lung cancer (NSCLC).

Materials and Methods: We retrospectively reviewed the records of 137 patients with inoperable stage III?IV NSCLC who received second-line chemotherapy. The effects of clinical parameters on survival were analyzed and the hazard ratios (HR) for mortality were identified by a Cox regression analysis.

Results: Sex, age older than 65 years, smoking history, cell type, T-stage, best response to first-line chemotherapy and first-line chemotherapy regimen were significant negative predictors in univariate analysis. The multivariate analysis showed that patients older than 65 years (HR, 1.530; 95% confidence interval [CI], 1.020?2.297), advanced T stage (T4 vs. T1; HR, 2.273; 95% CI, 1.010?5.114) and non-responders who showed progression with first-line chemotherapy (HR, 1.530; 95% CI, 1.063?2.203) had higher HR for death.

Conclusion: The age factor, T stage and responsiveness to first-line chemotherapy were important factors in predicting the outcome of patients with advanced NSCLC who received second-line chemotherapy. The results may help to predict outcomes for these patients in the future.
KEYWORD
Age Groups, Carcinoma, Non-Small-Cell Lung, Drug Therapy, Survival
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø